These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7792529

  • 1. [Mechanisms of bone loss in osteoporosis].
    Chavassieux P, Meunier PJ.
    Rev Prat; 1995 May 01; 45(9):1083-8. PubMed ID: 7792529
    [Abstract] [Full Text] [Related]

  • 2. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
    Steiniche T.
    APMIS Suppl; 1995 May 01; 51():1-44. PubMed ID: 7669370
    [Abstract] [Full Text] [Related]

  • 3. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E.
    Osteoporos Int; 2003 May 01; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [Abstract] [Full Text] [Related]

  • 4. Osteoporosis--a review.
    Alden JC.
    Clin Ther; 1989 May 01; 11(1):3-14. PubMed ID: 2655904
    [Abstract] [Full Text] [Related]

  • 5. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P.
    APMIS Suppl; 2001 May 01; (102):1-52. PubMed ID: 11419022
    [Abstract] [Full Text] [Related]

  • 6. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.
    Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS.
    J Clin Invest; 1983 Oct 01; 72(4):1396-409. PubMed ID: 6630513
    [Abstract] [Full Text] [Related]

  • 7. Osteoporosis. Efficacy and safety of a bisphosphonate dosed once weekly.
    Baran D.
    Geriatrics; 2001 Mar 01; 56(3):28-32. PubMed ID: 11252758
    [Abstract] [Full Text] [Related]

  • 8. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
    Riggs BL, Khosla S, Melton LJ.
    J Bone Miner Res; 1998 May 01; 13(5):763-73. PubMed ID: 9610739
    [Abstract] [Full Text] [Related]

  • 9. A stochastic analysis of iliac trabecular bone dynamics.
    Reeve J.
    Clin Orthop Relat Res; 1986 Dec 01; (213):264-78. PubMed ID: 3780102
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of osteoporosis: current data and prospects].
    Reginster JY, Deroisy R, Franchimont P.
    Rev Rhum Ed Fr; 1994 Dec 15; 61(10 Pt 2):155S-164S. PubMed ID: 7858567
    [Abstract] [Full Text] [Related]

  • 11. Cortical and trabecular bone distribution in the femoral neck in osteoporosis and osteoarthritis.
    Blain H, Chavassieux P, Portero-Muzy N, Bonnel F, Canovas F, Chammas M, Maury P, Delmas PD.
    Bone; 2008 Nov 15; 43(5):862-8. PubMed ID: 18708176
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G, Ziegler R.
    Ther Umsch; 1994 Nov 15; 51(11):737-47. PubMed ID: 7839332
    [Abstract] [Full Text] [Related]

  • 13. Treatment of osteoporosis in the elderly.
    Nordin BE, Need AG, Horowitz M, Morris HA.
    Clin Geriatr Med; 1994 Nov 15; 10(4):625-46. PubMed ID: 7850694
    [Abstract] [Full Text] [Related]

  • 14. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P, Krpan D, Krvavica A, Vukelić Baturić T, Fistonić I, Kusec V.
    Acta Med Croatica; 2004 Nov 15; 58(1):5-11. PubMed ID: 15125387
    [Abstract] [Full Text] [Related]

  • 15. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD, Hanley DA, Lorraine JK, Yu M.
    Clin Ther; 2007 Sep 15; 29(9):2055-67. PubMed ID: 18035204
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U.
    J Assoc Physicians India; 2008 Jun 15; 56():418-24. PubMed ID: 18822620
    [Abstract] [Full Text] [Related]

  • 17. [Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate].
    Wüster C, Heilmann P.
    Fortschr Med; 1997 Oct 20; 115(29):37-42. PubMed ID: 9445833
    [Abstract] [Full Text] [Related]

  • 18. Osteoporosis: new hope for the future.
    Masi L, Bilezikian JP.
    Int J Fertil Womens Med; 1997 Oct 20; 42(4):245-54. PubMed ID: 9309458
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of bone loss.
    Murray TM.
    J Rheumatol Suppl; 1996 Aug 20; 45():6-10. PubMed ID: 8856644
    [Abstract] [Full Text] [Related]

  • 20. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr 20; 17(94):68-72. PubMed ID: 18536138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.